'I’m worried that I’m not going to have a test that is available, that hasn’t expired yet, in the event that I need it.'
Nora Boydstun is diligent about checking expiration dates. So when she received her latest batch of four free at-home COVID-19 tests from the U.S. government in December, she quickly noticed that their packages listed expiration dates in July or August 2022.by six months, but even with that extra time, two of Boydstun’s tests were only valid until Jan. 2. That meant she had two days to use them once they arrived. The other two tests expire in a month.
Other people have reported similar issues and confusion after the latest round of tests started shipping on Dec. 19. Some of the newly delivered iHealth tests fromexpire in the next month or so, according to their extended dates. It’s not clear how many such tests were distributed. Zach Rogers, who lives in Portland, Ore., said he received his free iHealth tests just before Christmas. They’re due to expire on Feb. 14.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The FDA approves an Alzheimer's drug that appears to modestly slow the diseaseThe Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease. (Story aired on Weekend Edition Saturday on Jan. 6, 2023.)
Read more »
Day One to submit its glioma drug to the FDA this yearShares of Day One Pharmaceuticals Inc. jumped 21% in premarket trading on Monday after the company shared positive data from an ongoing Phase 2 clinical...
Read more »
FDA approves Alzheimer’s drug lecanemab amid safety concernsReports of deaths potentially linked to the treatment have cast a shadow on what many hail as a landmark approval.
Read more »
FDA approves new Alzheimer’s drug, but its price tag is raising concerns among advocatesA new breakthrough Alzheimer's drug is giving people hope, but the cost is raising concern among advocates.
Read more »
FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge DrugsThe agency is placing more holds on trials to protect patients and ensure studies are designed properly, a Wall Street Journal review found.
Read more »
FDA paused trials for experimental drugs more often in recent yearsThe Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years, a possible byproduct of newer medical technologies that offer promise but may pose additional risks.
Read more »